Breast Atypical Hyperplasia — Trials

Breast Atypical Hyperplasia — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04570956	Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk	terminated	Phase 2	65	Mayo ClinicOTHER	1	Sep 24, 2026	clinicaltrials
NCT05755269	Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women	terminated	—	19	Mayo ClinicOTHER	1	May 1, 2026	clinicaltrials
NCT03505372	Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia	terminated	N/A	5	Dana-Farber Cancer InstituteOTHER	1	Feb 11, 2020	clinicaltrials

Data updated 4 days agoSource updated Sep 24, 2026source: clinicaltrials